Medicine and Dentistry
Absorbed Dose
41%
Actinium 225
8%
Affibody Molecule
5%
Albumin
8%
Biodistribution
9%
Bone Marrow Toxicity
5%
Clinical Trial
9%
Combination Therapy
14%
DNA Damage
10%
Dose Response
15%
Dosimetry
50%
External Beam Radiotherapy
5%
Gallium 68
7%
Indium 111
5%
Lutetium 177
78%
Metastatic Carcinoma
6%
Microsphere
9%
Neoplasm
32%
Nephrotoxicity
6%
Neuroendocrine Tumor
18%
Nuclear Medicine
7%
Peptide Receptor
23%
Polyethylene Terephthalate
8%
Positron Emission Tomography
7%
Positron Emission Tomography-Computed Tomography
5%
Prostate Cancer
36%
Prostate Specific Membrane Antigen
16%
Radiation Biology
9%
Radioactive Tracer
5%
Radioembolization
7%
Radioisotope
9%
Radioligand
6%
Radionuclide Therapy
45%
Radiopharmaceutical
8%
Salivary Gland
6%
Single Photon Emission Computed Tomography-Computed Tomography
7%
Somatostatin Receptor
10%
Systematic Review
7%
Targeted Radionuclide Therapy
16%
Tetraxetan
17%
Treatment Response
5%
Tumor Cell
7%
Xenograft
6%
Yttrium 90
8%
Pharmacology, Toxicology and Pharmaceutical Science
Actinium 225
17%
Albumin
8%
Biodistribution
13%
Bone Marrow Toxicity
5%
Cholecystokinin B Receptor
5%
Clinical Dosimetry
7%
Clinical Trial
10%
Combination Therapy
15%
Diseases
6%
Dosimetry
51%
Gallium 68
5%
Gastrin Releasing Peptide Receptor
7%
Indium 111
5%
Lead 203
6%
Lutetium 177
100%
Malignant Neoplasm
6%
Neoplasm
36%
Nephrotoxicity
6%
Neuroendocrine Tumor
26%
Pharmacokinetics
5%
Polyethylene Terephthalate
16%
Preclinical Study
5%
Prostate Cancer
36%
Prostate Specific Membrane Antigen
25%
Radioisotope
69%
Radioligand
15%
Receptor
28%
Somatostatin Receptor
11%
Tetraxetan
23%
Tracer
6%
Yttrium 90
6%